Published in Pol J Pathol on January 01, 2007
Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer. Breast Cancer Res Treat (2005) 1.66
Clinical significance of interleukin-6 (IL-6) gene polymorphism and IL-6 serum level in pancreatic adenocarcinoma and chronic pancreatitis. Dig Dis Sci (2008) 1.65
[Diagnosis and treatment of thyroid cancer - Polish guidelines]. Endokrynol Pol (2010) 1.56
Aggressive fibromatosis (desmoid tumors): definition, occurrence, pathology, diagnostic problems, clinical behavior, genetic background. Pol J Pathol (2006) 1.23
DNA damage and repair in type 2 diabetes mellitus. Mutat Res (2004) 1.16
Basal, oxidative and alkylative DNA damage, DNA repair efficacy and mutagen sensitivity in breast cancer. Mutat Res (2004) 1.09
Proinflammatory and immunosuppressive serum, ascites and cyst fluid cytokines in patients with early and advanced ovarian cancer and benign ovarian tumors. Neuro Endocrinol Lett (2010) 1.08
Polymorphisms of the BRCA2 and RAD51 genes in breast cancer. Breast Cancer Res Treat (2005) 1.01
The prevalence of cationic trypsinogen (PRSS1) and serine protease inhibitor, Kazal type 1 (SPINK1) gene mutations in Polish patients with alcoholic and idiopathic chronic pancreatitis. Dig Dis Sci (2010) 1.00
Multiple congenital epuli (congenital granular cell tumours) in the newborn: a case report and review of literature. Pol J Pathol (2011) 0.94
Androgen receptor status in female breast cancer: RT-PCR and Western blot studies. J Cancer Res Clin Oncol (2001) 0.93
Polymorphism of the homologous recombination repair genes RAD51 and XRCC3 in breast cancer. Exp Mol Pathol (2009) 0.92
Genetics polymorphism in DNA repair genes by base excision repair pathway (XRCC1) and homologous recombination (XRCC2 and RAD51) and the risk of breast carcinoma in the Polish population. Pol J Pathol (2010) 0.91
Segmental congenital defect of the intestinal musculature. Pol J Pathol (2010) 0.90
RAD51 genotype and triple-negative breast cancer (TNBC) risk in Polish women. Pol J Pathol (2013) 0.90
Expression of TopBP1 in hereditary breast cancer. Mol Biol Rep (2012) 0.89
Association between the c.*229C>T polymorphism of the topoisomerase IIβ binding protein 1 (TopBP1) gene and breast cancer. Mol Biol Rep (2013) 0.89
Analysis of the G/C polymorphism in the 5'-untranslated region of the RAD51 gene in breast cancer. Acta Biochim Pol (2003) 0.89
Polymorphisms of the DNA polymerase beta gene in breast cancer. Breast Cancer Res Treat (2006) 0.88
Polymorphisms of the DNA mismatch repair gene HMSH2 in breast cancer occurence and progression. Breast Cancer Res Treat (2005) 0.87
Concentration of cadmium, nickel and aluminium in female breast cancer. Pol J Pathol (2011) 0.87
135G>C and 172G>T polymorphism in the 5' untranslated region of RAD51 and sporadic endometrial cancer risk in Polish women. Pol J Pathol (2011) 0.86
Single nucleotide polymorphisms in the homologous recombination repair genes and breast cancer risk in Polish women. Tohoku J Exp Med (2011) 0.86
Free radical scavengers can differentially modulate the genotoxicity of amsacrine in normal and cancer cells. Mutat Res (2003) 0.86
TGF-beta signaling is disrupted in endometrioid-type endometrial carcinomas. Gynecol Oncol (2004) 0.85
PCR analysis of matrix metalloproteinase 3 (MMP-3) gene promoter polymorphism in ovarian cancer. Pol J Pathol (2003) 0.85
The DNA-damaging potential of tamoxifen in breast cancer and normal cells. Arch Toxicol (2007) 0.84
Role of cyclooxygenase-2 gene polymorphisms in pancreatic carcinogenesis. World J Gastroenterol (2011) 0.83
Clinical significance of K-ras and c-erbB-2 mutations in pancreatic adenocarcinoma and chronic pancreatitis. Int J Gastrointest Cancer (2005) 0.82
Loss of heterozygosity and microsatellite instability at RAD52 and RAD54 loci in breast cancer. Pol J Pathol (2006) 0.81
The expression of SOCS1 and TLR4-NFkappaB pathway molecules in neoplastic cells as potential biomarker for the aggressive tumor phenotype in laryngeal carcinoma. Folia Histochem Cytobiol (2009) 0.81
Metallothionein 2A genetic polymorphisms and risk of ductal breast cancer. Clin Exp Med (2012) 0.81
Orally administered novel cyclic pentapeptide P-317 alleviates symptoms of diarrhoea-predominant irritable bowel syndrome. J Pharm Pharmacol (2014) 0.81
Expression of erbB-1 and erbB-2 genes in normal and pathological human endometrium. Oncol Rep (2007) 0.81
A multi-faceted analysis of RutD reveals a novel family of α/β hydrolases. Proteins (2012) 0.80
Germline BRCA1 mutations and G/C polymorphism in the 5'-untranslated region of the RAD51 gene in Polish women with breast cancer. Pol J Pathol (2005) 0.80
Analysis of nm23-H1 protein immunoreactivity in follicular thyroid tumors. Pol J Pathol (2004) 0.80
Anti-inflammatory and antinociceptive action of an orally available nociceptin receptor agonist SCH 221510 in a mouse model of inflammatory bowel diseases. J Pharmacol Exp Ther (2013) 0.80
MMAC/PTEN gene expression in endometrial cancer: RT-PCR studies. Pol J Pathol (2006) 0.79
Analysis of APC, alpha-, beta-catenins, and N-cadherin protein expression in aggressive fibromatosis (desmoid tumor). Pathol Res Pract (2009) 0.79
Analysis of the polymorphisms in non-homologous DNA end joining (NHEJ) gene Ku70 and Ligase IV in sporadic breast cancer in women. Pol J Pathol (2010) 0.79
XPD Lys751Gln polymorphism analysis in women with sporadic breast cancer. Pol J Pathol (2007) 0.79
[Polymorphisms in XRCC1 and ERCC4/XPF DNA repair genes and associations with breast cancer risk in women]. Pol Merkur Lekarski (2007) 0.79
Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II. Folia Histochem Cytobiol (2011) 0.79
Different distribution of c-kit positive interstitial cells of Cajal-like in children's urinary bladders. Folia Histochem Cytobiol (2011) 0.78
The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I. Folia Histochem Cytobiol (2011) 0.78
TGFβ-pathway is down-regulated in a uterine carcinosarcoma: a case study. Pathol Res Pract (2013) 0.78
Molecular basis of taste sense: involvement of GPCR receptors. Crit Rev Food Sci Nutr (2014) 0.78
Impact of EGFR immunoexpression on STAT3 activation and association with proinflammatory/regulatory cytokine pattern in laryngeal squamous cell carcinoma. Oncol Rep (2009) 0.78
Dinucleotide repeat polymorphisms of RAD51, BRCA1, BRCA2 gene regions in breast cancer. Pathol Int (2008) 0.78
Expression of TGF-beta type I and II receptors in normal and cancerous human endometrium. Cancer Lett (2002) 0.77
XRCC1 and XRCC3 DNA repair gene polymorphisms in breast cancer women from the Lodz region of Poland. Pol J Pathol (2009) 0.77
Plasminogen activator inhibitor 1 (PAI-1) 1334G/A genetic polymorphism in colorectal cancer. Acta Biochim Pol (2003) 0.77
Analysis of P161NK4A protein expression in follicular thyroid tumors. Pol J Pathol (2004) 0.77
The -173 G/C polymorphism of the promoter region macrophage migration inhibitory factor gene is not associated with incidence of pulmonary hamartoma. Pol J Pathol (2007) 0.77
Alterations of Chk1 and Chk2 expression in colon cancer. Int J Colorectal Dis (2008) 0.77
The polymorphisms of the CYP17 and CYP19 genes in endometrial cancer patients. Pol J Pathol (2006) 0.76
Amplification of Her-2/neu oncogene in GERD - Barrett's metaplasia – dysplasia - adenocarcinoma sequence. Hepatogastroenterology (2013) 0.76
Analysis of TGF-beta protein expression in aggressive fibromatosis (desmoid tumor). Pol J Pathol (2006) 0.76
Expression of endoglin in primary endometrial cancer. Oncology (2011) 0.76
Androgen receptor versus erbB-1 and erbB-2 expression in human prostate neoplasms. Oncol Rep (2004) 0.76
[The G/C polymorphism of RAD51 gene in breast cancer]. Pol Merkur Lekarski (2006) 0.76
[Histopathological diagnosis of thyroid cancer in a multicenter trial]. Endokrynol Pol (2006) 0.76
[The analysis of estrogen receptor alpha (ER-alpha) gene Pvull and Xbal polymorphisms in postmenopausal women with breast cancer]. Pol Merkur Lekarski (2008) 0.76
Analysis of pRb, p16INK4A proteins and proliferating antigens: PCNA, Ki-67 and MCM5 expression in aggressive fibromatosis (desmoid tumor). Histol Histopathol (2009) 0.75
Inhibition of telomerase activity in endometrial cancer cells by selenium-cisplatin conjugate despite suppression of its DNA-damaging activity by sodium ascorbate. Teratog Carcinog Mutagen (2002) 0.75
[The risk of endometrial cancer appearance and CYP19 and COMT gene polymorphism]. Pol Merkur Lekarski (2007) 0.75
[Comparable evaluation of usefulness of traditional methods and polymerase chain reaction technique in detection of Helicobacter pylori infection]. Pol Merkur Lekarski (2007) 0.75
Microsatellite instability (MSI) analysis in patients with endometrial cancer. Pol J Pathol (2005) 0.75
Frequency analysis of apoptosis in sporadic breast cancer. Pol J Pathol (2006) 0.75
[Is MDR 1 gene a key to successful chemotherapy?]. Ginekol Pol (2006) 0.75
Molecular cytogenetic analysis of chromosome aberrations in desmoid tumors. Pol J Pathol (2007) 0.75
Analysis of microsatellite instability and BRCA1 mutations in patients from hereditary nonpolyposis colorectal cancer (HNPCC) family. Pol J Pathol (2005) 0.75
[Acardiac fetus--morphological and clinical aspects]. Pol Merkur Lekarski (2005) 0.75
Genetic instability in the RAD51 and BRCA1 regions in breast cancer. Cell Mol Biol Lett (2006) 0.75
[The rare case of erosive lichen planus with large leasions in vulvar area and vagina]. Pol Merkur Lekarski (2007) 0.75
[Gastroschisis prenatally and postnatally]. Ginekol Pol (2006) 0.75
[Genetics analysis of microsatellite instability in patients from hereditary nonpolyposis colorectal cancer (HNPCC) families]. Pol Merkur Lekarski (2006) 0.75
[The spectrum of congenital malformations of the urinary tract in fetuses and newborns in autopsies in 1989-2002]. Pol Merkur Lekarski (2005) 0.75
The role of BRCA1 gene mutations and apoptosis phenomenon in sporadic breast cancer. Pol J Pathol (2005) 0.75
Analysis of P53 and P21WAF1 proteins expression in follicular thyroid tumors. Pol J Pathol (2004) 0.75
[Early amnion rupture and fetal and newborn defects as an obstetrical and pathomorphological problem]. Ginekol Pol (2005) 0.75
Analysis of cyclin D1 and retinoblastoma protein immunoreactivity in follicular thyroid tumors. Pol J Pathol (2005) 0.75
Glomerular basement membrane thinning in children: a morphometric assessment. Anal Quant Cytol Histol (2006) 0.75
[The coexistence of atopic dermatitis and psoriasis in a 12 months-old girl]. Pol Merkur Lekarski (2005) 0.75
[Cervical glandular intraepithelial neoplasia topography and the risk of conisation]. Ginekol Pol (2005) 0.75
Analysis of p27KIP1 protein and Ki-67 expression in aggressive fibromatosis (desmoid tumor). Pol J Pathol (2006) 0.75